Login
$VNDA
$3.99 +$0.05 (1.27%) Close

Company Executives

$VNDA Management Team

Dr. Mihael Polymeropoulos

Chairman of the Board

President

Chief Executive Officer

Age 65
Compensation $3.896M USD
Sex Male

Mr. Kevin Moran

Chief Financial Officer

Senior Vice President

Treasurer

Age 41
Compensation $1.448M USD
Sex Male

Mr. Joakim Wijkstrom

Senior Vice President

Chief Marketing Officer

Age 59
Compensation $1.061M USD
Sex Male

Mr. Timothy Williams

Senior Vice President

General Counsel

Secretary

Age 49
Compensation $1.453M USD
Sex Male

Mr. Gunther Birznieks

Senior Vice President - Business Development

Age 56
Compensation $1.423M USD
Sex Male
Directors
7
serving now
Independent
6 of 6
stated in the proxy; 1 not stated
Average tenure
9.6 years
from year joined
CEO also chairs the board
Yes
Mihael H. Polymeropoulos, M.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Richard W. Dugan
84 2005
21 years
Independent
Audit Committee
None stated $374,998
Charles C. Duncan, Ph.D.
63 2026
0 years
Independent None stated None stated Not stated
Anne Sempowski Ward
54 2019
7 years
Independent
Compensation Committee
SPS Commerce, Inc. $344,998
Mihael H. Polymeropoulos, M.D.
66 2003
23 years
Not stated None stated None stated Paid as CEO
Phaedra S. Chrousos
46 2019
7 years
Independent
Nominating/Corporate Governance Committee
None stated $339,998
Stephen Ray Mitchell, M.D.
74 2020
6 years
Independent None stated None stated $317,498
Tage Honoré, Ph.D., D.Sc.
75 2023
3 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

5 disclosed in the proxy filed Apr 23, 2026
Katerina Polymeropoulos
daughter of our Chief Executive Officer
$195,519
2025

Employment as Associate Director, Marketing Communications; 2025 total cash compensation

With the Company Open in proxy
Kaitlyn Goetsch
daughter of our Chief People Officer
$119,201
2025

Employment in the Clinical role; 2025 total compensation

With the Company Open in proxy
Dr. Polymeropoulos
party to a tax indemnity agreement with the Company
Amount not stated

Tax indemnity agreement reimbursing excise tax under Section 4999 and related taxes on change-in-control payments

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support